Oct 29 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP TO COLLABORATE WITH LABCORP TO DEVELOP ONCOLOGY SERVICES AND PRODUCTS
* IMMUTEP LTD - ELIGIBLE TO RECEIVE POTENTIAL UNDISCLOSED MILESTONE AND SERVICE-RELATED PAYMENTS
* IMMUTEP - COLLABORATION WITH LABCORP IS UNRELATED TO ANY OF CO'S OWN IN-HOUSE PHARMACEUTICAL DEVELOPMENT PROGRAMS IN CANCER OR AUTOIMMUNE DISEASE